Patients With Prostate Cancer clinical trials

Explore recruiting patients with prostate cancer clinical trials.

Recruiting patients with prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

THE EFFECT OF ABIRATERONE ON THE METABOLISM OF OXYCODONE (ENABLE study)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Radiometabolic Therapy (RMT) with 177Lu PSMA in PSMA PET/CT positive advanced/metastatic tumours: a basket trial (LUBASKET)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Basket of Baskets: A Modular, Open-label, Phase II, Multicentre Study To Evaluate Targeted Agents in Molecularly Selected Populations With Advanced Solid Tumours

Sweden, Netherlands, Spain, Germany, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy

Spain, Netherlands, France, Germany, Italy, Czechia +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ECETEP : Pilot study evaluating PSMA positron emission tomography for monitoring clinically significant prostate cancer after focal HIFU treatment

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase I study to evaluate the safety and dosimetry of 68Ga-OncoACP3 in patients with prostate cancer

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Patients With Prostate Cancer trials by city

Patients With Prostate Cancer in Toronto Patients With Prostate Cancer in Vancouver Patients With Prostate Cancer in Montreal Patients With Prostate Cancer in Calgary Patients With Prostate Cancer in Edmonton Patients With Prostate Cancer in Ottawa Patients With Prostate Cancer in Winnipeg Patients With Prostate Cancer in Quebec City Patients With Prostate Cancer in Hamilton Patients With Prostate Cancer in Kitchener Patients With Prostate Cancer in London Patients With Prostate Cancer in Halifax Patients With Prostate Cancer in New York Patients With Prostate Cancer in Los Angeles Patients With Prostate Cancer in Chicago Patients With Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease